Concord Biotech

BSE: 543960 28 Jun 2025

Healthcare

₹ 1822.5

Concord Biotech Limited specializes in Pharmaceuticals within the Healthcare sector.

Concord Biotech

BSE: 543960 28 Jun 2025

Healthcare

₹ 1822.5

Concord Biotech Limited specializes in Pharmaceuticals within the Healthcare sector.

Book Value

173.0

Dividend Yield

0.48%

Debt to Equity

0.0

Stock P/E

51.7

Market Cap

19,221 Cr

Concord Biotech - Share Price & Details

Market Cap

₹19,221

High /Low

2,664 / 1,345

Stock P/E

51.7

Book Value

₹173.0

Dividend Yield

0.48

ROCE

29.5

ROE

₹22.3

Face Value

1.0

PEG Ratio

2.63

EVEBITDA

₹35.0

Debt

2.97

CMP / FCF

139.0

Debt to equity

₹0.0

NP Ann

372

High price all time

2,664

Piotroski score

₹6.0

Graham Number

372.0

No. Eq. Shares

10.5

Net CF

₹-14.2

Net profit

372

Price to book value

10.6

Interest Coverage

₹934.0

Low price all time

900.0

Industry PE

32.0

Reserves

₹1,802

Free Cash Flow

₹134

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
Concord Biotech Limited	NA	NA	NA	NA	19,221	51.7
ALEMBIC PHARMACEUTICALS LTD.	15838.5	753.4	15706.4	3.83	19045	33.5
JUBILANT PHARMOVA LIMITED	2352.0	136.0	2173.0	0.86	18700	33.7

Peer Comparison Chart

About Concord Biotech

Concord Biotech Limited, with Security Code 543960, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y

(12 Jun 2025)

Discover the latest Business News, Budget 2025 News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries,...

Market Participants Recognise Concord Biotech Limited's (NSE:CONCORDBIO) Earnings Pushing Shares 30% Higher

(10 Jun 2025)

Concord Biotech Limited ( NSE:CONCORDBIO ) shareholders would be excited to see that the share price has had a great...

Concord Biotech Shows Resilience Amid Mixed Technical Indicators and Market Trends

(05 Jun 2025)

Concord Biotech has recently revised its market evaluation, with its stock showing a significant increase and strong weekly performance.

Concord Biotech Faces Mildly Bearish Shift Amid Declining Financial Performance

(22 May 2025)

Concord Biotech has recently experienced a change in its evaluation, reflecting a shift in its technical outlook. The company reported a net sales decline...

Declining Stock and Solid Fundamentals: Is The Market Wrong About Concord Biotech Limited (NSE:CONCORDBIO)?

(17 May 2025)

It is hard to get excited after looking at Concord Biotech's (NSE:CONCORDBIO) recent performance, when its stock has...

V MART RETAIL LTD LEADS LOSERS IN A GROUP

(13 May 2025)

Jindal Saw Ltd, Kotak Mahindra Bank Ltd, KFin Technologies Ltd and Concord Biotech Ltd are among the other losers in the BSE's 'A' group...

Quarterly Table

Standalone Consolidated

Metrics	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	194.8	262.3	240.8	319.0	215.8	310.2	244.2
Expenses	122.7	143.2	134.9	184.7	134.5	173.5	146.3
Operating Profit	72.2	119.2	105.9	134.3	81.3	136.7	98.0
OPM %	37.03%	45.43%	43.99%	42.1%	37.66%	44.06%	40.11%
Other Income	6.7	8.1	8.2	10.8	10.3	10.0	14.7
Interest	0.8	0.8	0.5	0.5	0.2	0.1	0.1
Depreciation	13.0	13.3	13.5	13.7	13.2	13.3	13.3
Profit before tax	65.0	113.2	100.1	130.9	78.2	133.3	99.3
Tax %	-25.4%	-25.3%	-25.5%	-25.7%	-25.5%	-26%	-25.4%
Net Profit	48.5	84.5	74.6	97.2	58.2	98.7	74.1
EPS in Rs	4.63	8.08	7.13	9.29	5.57	9.43	7.08

Metrics	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	194.8	262.3	240.8	319.0	215.8	310.2	244.2
Expenses	122.7	146.6	134.9	186.9	134.5	176.5	146.3
Operating Profit	72.2	115.7	105.9	132.1	81.3	133.7	98.0
OPM %	37.03%	44.11%	43.99%	41.41%	37.66%	43.11%	40.11%
Other Income	6.7	8.1	8.2	10.8	10.3	10.0	14.7
Interest	0.8	0.8	0.5	0.5	0.2	0.1	0.1
Depreciation	13.0	13.3	13.5	13.7	13.2	13.3	13.3
Profit before tax	65.0	109.7	100.1	128.7	78.2	130.3	99.3
Tax %	-25.4%	-25.3%	-25.5%	-25.7%	25.5%	26%	25.4%
Net Profit	54.5	81.0	77.6	95.0	59.6	95.7	75.9
EPS in Rs	5.21	7.74	7.41	9.08	5.7	9.15	7.26

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	18%
3 Years:	18%
TTM:	12%

Compounded Profit Growth
10 Years:	0%
5 Years:	20%
3 Years:	9%
TTM:	9%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	5%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	18%
TTM:	12%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	9%
TTM:	7%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	5%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Concord Biotech

Concord Biotech

Concord Biotech - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Concord Biotech

Latest News

Concord Biotech Standalone March 2025 Net Sales at Rs 429.88 crore, up 34.77% Y-o-Y

Market Participants Recognise Concord Biotech Limited's (NSE:CONCORDBIO) Earnings Pushing Shares 30% Higher

Concord Biotech Shows Resilience Amid Mixed Technical Indicators and Market Trends

Concord Biotech Faces Mildly Bearish Shift Amid Declining Financial Performance

Declining Stock and Solid Fundamentals: Is The Market Wrong About Concord Biotech Limited (NSE:CONCORDBIO)?

V MART RETAIL LTD LEADS LOSERS IN A GROUP

USFDA inspection at Concord Biotech’s API facility at Dholka

Concord Biotech Faces Technical Shift Amid Declining Sales and Profit Metrics

Concord Biotech Shares Surge 5% on Receiving USFDA Final Approval

Concord Biotech Faces Market Sentiment Shift Amid Declining Sales and Profits

Pharma stock jumps 9% receiving board’s approval to invest ₹6.9 Cr in Clean Max

This biotech stock falls over 30% in two days after Q3 earnings, wiping out ₹1,600 crore from Rakesh Jhunjhunwala’s portfolio

Earnings Miss: Here's What Concord Biotech Limited (NSE:CONCORDBIO) Analysts Are Forecasting For Next Year

Concord Biotech shares plunge 16% on reporting Q3 results; PAT down 2% YoY

Concord Biotech shares locked in 20% lower circuit after weak Q3 earnings

Concord Biotech shares tumble 16% after weak Q3 earnings

Concord Biotech Ltd Slips 10.64%

Trade Spotlight: How should you trade Escorts Kubota, NALCO, BSE, Minda Corporation, Concord Biotech,...

Concord Biotech Stock Declines 3.1% on January 15, 2025, Despite Strong Market Position

Concord Biotech Reports 4.25% Gain on January 13, 2025, Outperforming Sector by 4.45%

CONCORD BIOTECH Share Price Today Down 4%

Concord Biotech Share Price Up 8.87% To ₹2,401 – Analysts Eye Future Potential

Concord Biotech Gains 3.21% on December 26, Outperforming Sector by 2.64%

Concord Biotech Posts 4.84% Gain, Ending Four-Day Decline

CONCORD BIOTECH Share Price Today Up 4%

Upcoming IPO: Concord Enviro Systems public offer to open on December 19. Check price band, issue size and more | Stock Market News

Concord Biotech invests $10 lakh in Palvella Therapeutics

Concord Biotech Invests in Palvella Therapeutics for Groundbreaking Skin Drug

Concord Biotech invests USD 10 lakh in Palvella Therapeutics

Concord Biotech's Stock Soars 3.08%, Outperforms Sector and Sensex

Concord Biotech - Bullish Momentum: 10 stocks with White Marubozu Pattern on November 29

Concord Biotech's Stock Soars, Outperforms Sector and Sensex with Impressive Gains

Concord Biotech's Stock Performance Soars, MarketsMOJO Gives 'Buy' Call

Stock Radar: 50% rally in 1 year; wait for confirmation of rounding bottom pattern to go long in Concord Biotech

What should investors do with Concord Biotech?

Stock Radar: 50% rally in 1 year; wait for confirmation of rounding bottom pattern to go long in Concord B

Concord Biotech Consolidated September 2024 Net Sales at Rs 310.18 crore, up 18.23% Y-o-Y

Amber Enterprises India Ltd leads gainers in 'A' group

Jhunjhunwala stock portfolio down 13% amid market correction; top 5 stocks fall up to 24%

Concord Biotech Reports Strong Financial Results, Receives 'Buy' Call from MarketsMOJO

Is this Jhunjhunwala-backed pharma stock still a buy after 30% correction?

Concord Biotech Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Concord Biotech Second Quarter 2025 Earnings: Beats Expectations

Concord Biotech Standalone September 2024 Net Sales at Rs 310.18 crore, up 18.23% Y-o-Y

Is Concord Biotech Limited's (NSE:CONCORDBIO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter

Concord Biotech's Stock Sees Temporary Dip, But Remains a Strong Player in Pharma Industry

Concord Biotech Receives 'Hold' Rating from MarketsMOJO, Strong Fundamentals and Growth Potential Remain

Concord Biotech - Concurrent Gainers: 12 stocks that gained for 5 days in a row

Concord Biotech's Stock Surges 5.45%, Outperforms Sector and Receives 'Buy' Call from MarketsMOJO

CONCORD BIOTECH Share Price Today Up 7%

Concord Biotech's Stock Soars, Outperforms Sector and Sensex with Consistent Growth

Concord Biotech Receives 'Buy' Rating from MarketsMOJO, Strong Fundamentals and Bullish Trend Drive Upgrade

Concord Biotech's Stock Sees 4.27% Increase, Outperforms Sector and Sensex

Concord Biotech's Stock Sees Slight Dip, But Experts Remain Positive

Concord Biotech's Stock Sees Temporary Dip, But Overall Outlook Remains Positive

Concord Biotech's Stock Sees Slight Dip, But Remains a 'Buy' According to MarketsMOJO

Concord Biotech's Stock Soars to New High, Outperforms Sector and Market

UBS Offloads Shares Worth Rs 480 Crore In Four Companies

Vanguard Group Acquires Nearly Rs 1,000 Crore In Shares Across Seven Companies

Concord Biotech - These 5 BSE smallcap stocks see price and volume jump in last 3 days

UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals

Brokerage Radar: Investec upgrades Union Bank to 'Buy', Kotak downgrades Concord Biotech

Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention?

Concord Biotech Receives 'Buy' Rating from MarketsMOJO Based on Strong Fundamentals and Bullish Trend

Concord Biotech: Strong grip on fermentation APIs stays

Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'

Stocks hit 52-week highs: Gujarat Gas, Concord Biotech, Hindustan Petroleum, Bajaj Finserv, Godrej Industries, Bikaji Foods and more

Volumes jump at Concord Biotech Ltd counter

Concord Biotech shares rally over 12% to hit new record highs; check details

Technical Breakout Stocks: How to trade Godfrey Phillips, GSPL & Concord Biotech on Friday?